Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non–African American women

JAMA Cardiology

Volumn 2, Issue 11, 2017, Pages 1256-1260

  Irizarry, Olga Corazón ^a   Levine, Lisa D ^a   Lewey, Jennifer ^a   Boyer, Theresa ^b   Riis, Valerie ^a   Elovitz, Michal A ^a   Arany, Zolt ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGE; ANCESTRY GROUP; ARTICLE; CARDIOVASCULAR MORTALITY; CESAREAN SECTION; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; DETERIORATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL RECORD REVIEW; NON AFRICAN AMERICAN; PERIPARTUM CARDIOMYOPATHY; PREECLAMPSIA; PRESCRIPTION; PRIORITY JOURNAL; PUERPERIUM; RETROSPECTIVE STUDY; TWIN PREGNANCY; ASIAN AMERICAN; CARDIOMYOPATHY; CAUCASIAN; DISEASE EXACERBATION; ETHNOLOGY; HEART STROKE VOLUME; HEART TRANSPLANTATION; HISPANIC; HYPERTENSION; KAPLAN MEIER METHOD; MORTALITY; PATHOPHYSIOLOGY; PERINATAL PERIOD; PREGNANCY; PREGNANCY COMPLICATION; PUERPERAL DISORDER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UNITED STATES; YOUNG ADULT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AFRICAN AMERICANS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASIAN AMERICANS; CARDIOMYOPATHIES; COHORT STUDIES; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART TRANSPLANTATION; HISPANIC AMERICANS; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; KAPLAN-MEIER ESTIMATE; MORTALITY; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY, TWIN; PUERPERAL DISORDERS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85034633274     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.3574     Document Type: Article

References (15)

1. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al; Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767-778.
2. Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation. 2016;133(14):1397-1409.
3. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283 (9):1183-1188.
4. Bello NA, Arany Z. Molecular mechanisms of peripartum cardiomyopathy: a vascular/hormonal hypothesis. Trends Cardiovasc Med. 2015;25(6): 499-504.
5. Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485(7398):333-338.
6. Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014;11(6):364-370.
7. Ware JS, Li J, Mazaika E, et al; IMAC-2 and IPAC Investigators. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016;374(3):233-241.
8. Harper MA, Meyer RE, Berg CJ. Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol. 2012;120(5):1013-1019.
9. McNamara DM, Elkayam U, Alharethi R, et al; IPAC Investigators. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015;66(8):905-914.
10. Goland S, Modi K, Hatamizadeh P, Elkayam U. Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail. 2013;19(4):214-218.
11. Levine LD, Bogner HR, Hirshberg A, Elovitz MA, Sammel MD, Srinivas SK. Term induction of labor and subsequent preterm birth. Am J Obstet Gynecol. 2014;210(4):354.e1-354.e8.
12. Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62(18): 1715-1723.
13. Feinstein M, Ning H, Kang J, Bertoni A, Carnethon M, Lloyd-Jones DM. Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis. Circulation. 2012;126(1):50-59.
14. Lu Y, Ezzati M, Rimm EB, Hajifathalian K, Ueda P, Danaei G. Sick populations and sick subpopulations: reducing disparities in cardiovascular disease between blacks and whites in the United States. Circulation. 2016;134(6): 472-485.
15. Sheppard R, Hsich E, Damp J, et al; IPAC Investigators. GNB3 C825T polymorphism and myocardial recovery in peripartum cardiomyopathy: results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study. Circ Heart Fail. 2016;9(3): e002683.